Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Fibrobiologics Fblg Stock Losing Momentum Price At 1.38 Up 3.76 20260402 Figr Stock Analysis Figure Technology Solutions Inc Gains 4.93 Percent To Hit 34.51 Dollar Level 20260403 1 What Makes Myers Industries Mye Stock Attractive Or Not Price At 21.94 Up 4.13 20260408 Daily Market Overview Dow S And P 500 Nasdaq Post Solid Broad Gains 20260409 1 Is Boston Sci Bsx Stock In An Uptrend Price At 62.52 Down 0.48 20260406 ODDITY Tech Ltd ODD notches strong Q4 2025 EPS beat shares climb on positive investor sentiment Global GLP Stock Movement Analysis Grinds Higher 20260418 Is Karyopharm Therapeutics KPTI stock considered a safe play Q4 2025 Below Expectations DTE2080Bond DTB Stock Trending Today 032 20260415 Is Brandywine BDN stock positioned for growth Q1 2026 Earnings Beat Estimates XFOR X4 Pharmaceuticals beats Q1 2026 EPS estimates by 216 percent shares climb 3 percent Roma Green ROMA Stock Risk Factors 1048 20260420 Should I buy Ryerson RYZ stock Smart Money Flows 20260420 SuRo Capital SSSS Stock Private Repurchase Trend Weakens 20260420 How does First FFIN make money 257 20260429 JFBRW Jeffs quarterly earnings metrics not yet public with leadership set to share strategic outlook and results soon How Ferguson Enterprises FERG cash generation compares to earnings Ferguson Enterprises Matches Forecasts CPSS CPS Q4 2025 EPS falls 105 percent short of analyst estimates shares dip 044 percent STOK Stoke Therapeutics EPS beats estimates by 63 as losses narrow yet shares decline 147 How AI Is Accelerating New Business Formation With Gen Z Entrepreneurs Leading the Charge Dave Ramseys Blunt Advice to Uber Driver Who Spent 144K on Cars Youve Been Working for Free Voluntary Repo Weighed EU to Ban Brazilian Meat Imports Amid Trade Deal Tensions Sunoco LP SUN Q1 2026 Earnings Beat Revenue NA EPS 285 Why Smithfield Foods SFD Just Surged 268 Key Levels Ahead 20260518 Achieve Life ACHV Gains 134 Support Holds at 574 20260514 Palo Alto PANW Q1 2026 Beat Revenue NA EPS Exceeds by Significant Core Inflation Hits 32 in March as Q1 GDP Growth Disappoints at 2 Stocks to Watch LIC ITC RVNL Dr Reddys Among 10 Shares in Focus on May 21 as Gift Nifty Signals Positive Start US Charges Cubas Ral Castro with Murder in 1996 Plane Downing Case HR Block HRB Q1 2026 Earnings Surprise EPS 602 Up Significant Meta Broadcom and Industry Leaders Launch 125 Million Semiconductor Research Hub at UCLA NFL Seeks Ban on Certain Sports Prediction Contracts Including GameSpecific Bets and Injury Markets Mortgage Rates Fluctuate 30Year Fixed at 634 as Market Eyes Treasury Yields and Geopolitical Risks Samsung Shares Surge After Strike Averted Bonus Concerns Linger AI Job Applications Create a Doom Loop for Recruiters and Candidates FIS Q1 2026 Earnings EPS Surpasses Estimates by 46 Despite Minor Stock Dip Gladstone Investment Corporation Q1 2026 Earnings Mixed Quarter as EPS Misses Estimates Notes Edge Higher BRBR Q1 2026 Earnings EPS Falls Sharply Short of Estimates Shares Decline GameStop GME Q1 2026 Earnings EPS Surges Past Estimates on Cost Discipline Revenue Remains Undisclosed PMN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Neurodegenerative Pipeline HLX Stock Advances Slightly as Helix Energy Solutions Holds Key Support BingEx FLX Rallies from Support Testing Key Resistance at 237 Aemetis Inc AMTX Surges 19 as Renewable Fuel Stock Breaks Resistance CPRT Copart Inc DE reports 10 percent Q1 2026 EPS miss but shares notch small gains amid muted investor sentiment Nephros NEPH Stock Technical Trend Momentum Building 20260415 Why AMC Ent AMC business model holds up in any market 132 20260508 DGICB Donegal Group Inc Q4 2025 earnings miss estimates shares edge higher despite mild year over year revenue declines ADACU Am Drive Acq quarterly results pending as acquisition pipeline evaluation continues amid market uncertainty Endeavour EXK Stock Weekly Review 120 20260415 VRDN Viridian Therapeutics Inc posts narrow Q4 2025 EPS beat and explosive revenue growth as shares dip modestly